The Neuropsychiatric Inventory

  title={The Neuropsychiatric Inventory},
  author={Jeffrey L. Cummings},
  pages={10S - 16S}
  • J. Cummings
  • Published 1 May 1997
  • Psychology, Medicine
  • Neurology
The Neuropsychiatric Inventory (NPI) was developed to assess psychopathology in dementia patients. [] Key Method It evaluates 12 neuropsychiatric disturbances common in dementia: delusions, hallucinations, agitation, dysphoria, anxiety, apathy, irritability, euphoria, disinhibition, aberrant motor behavior, night-time behavior disturbances, and appetite and eating abnormalities.

Tables from this paper

Neuropsychiatric assessment of Alzheimer’s disease and related dementias

The NPI is a valid and reliable means of assessing neuropsychiatric symptoms in patients with dementia and correlates with increasing disability in activities of daily living and increasing cognitive impairment.

Neuropsychiatric Symptoms of Alzheimer’s Disease in Down Syndrome and Its Impact on Caregiver Distress

NPS are frequent and severe in individuals with DS and AD, contributing to caregiver distress, and must be considered of critical relevance demanding management and treatment.

Prevalence and clinical correlates of neuropsychiatric symptoms in dementia

It is found that neuropsychiatric symptoms were common, with approximately three-fourths of the subjects exhibiting at least one symptom during the preceding month, and frequency and severity of symptoms were similar for the all-dementia and Alzheimer's disease–only groups.

An Itemized Approach to Assessing Behavioral and Psychological Symptoms in Dementia

Results indicate an itemized approach to assessing behavioral and psychological symptoms in dementia among patients with mild-to-moderate dementia can be reliable, has the power to capture multiple features of neuropsychiatric symptoms, and can produce a rich neurobehavioral profile adding valuable information to the diagnosis and treatment of these patients.

Assessment of neuropsychiatric symptoms in dementia: validity and reliability of the Lebanese version of the neuropsychiatric inventory questionnaire

The Arabic version of the NPI-Q showed evidence of good psychometric properties indicating that it is a suitable tool for the routine assessment of neuropsychiatric symptoms for Lebanese patients with dementia in clinical settings.

Neuropsychiatric symptom clusters of Alzheimer disease in Hong Kong Chinese: correlates with caregiver burden and depression.

  • Sheung-Tak ChengL. LamT. Kwok
  • Psychology, Medicine
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
  • 2013

Concurrent validity of neuropsychiatric subgroups on caregiver burden in Alzheimer disease patients.

  • S. TunD. MurmanC. Colenda
  • Psychology, Medicine
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
  • 2008
Neuropsychiatric subgroups were able to differentially predict caregiver burden and appear to lend further support to the validity of classifying neuropsychiatric symptoms in AD patients using cluster analysis.

The reliability and validity of the Turkish version of the Neuropsychiatric Inventory-Clinician.

The Turkish version of the NPI-C scale was found to be a reliable and valid instrument to assess neuropsychiatric symptoms in Turkish elderly subjects with AD.

Neuropsychiatric inventory workshop: behavioral and psychologic symptoms of dementia in Asia.

The NPI was the subject of a workshop in Asia in conjunction with the International Workgroup on Dementia Drug Guidelines and investigators using the NPI from 4 Asian areas presented conclusions from their research.



The Neuropsychiatric Inventory

The NPI has the advantages of evaluating a wider range of psychopathology than existing instruments, soliciting information that may distinguish among different etiologies of dementia, differentiating between severity and frequency of behavioral changes, and minimizing administration time.

The spectrum of behavioral changes in Alzheimer's disease

Agitation, dysphoria, apathy, and aberrant motor behavior were significantly correlated with cognitive impairment in patients with Alzheimer's disease compared with normal age-matched control subjects.

Depressive Symptoms in Alzheimer Disease: Assessment and Determinants

The results suggest that depression in AD is not severe and is unrelated to patient self-awareness of illness, and it is hypothesized that the cholinergic deficit of AD may ameliorate depressive symptoms.

Delusions in dementia syndromes: investigation of behavioral and neuropsychological correlates.

It is hypothesized that delusions are independent noncognitive manifestations of the neurobiology of AD and MID and that delusional patients are more behaviorally disturbed than those without delusions.

Alzheimer disease and frontotemporal dementias. Behavioral distinctions.

The Neuropsychiatric Inventory provides a behavioral profile that differentiates patients with FTD from patients with AD, and are more behaviorally disturbed but are often less depressed than patients withAD relative to their level of apathy.

Biologic Markers and Neurochemical Correlates of Agitation and Psychosis in Dementia

  • M. KirbyB. Lawlor
  • Psychology, Medicine
    Journal of geriatric psychiatry and neurology
  • 1995
The evidence for biologic and neurochemical correlates of psychosis and agitation in dementia, and the treatment implications for these findings are reviewed.

Effect of Tacrine on Behavioral Symptoms in Alzheimer's Disease: An Open-Label Study

It is suggested that tacrine may be beneficial for selected behavioral symptoms in AD patients, particularly at higher doses and in those with moderate cognitive deficits.

Psychosis and physical aggression in probable Alzheimer's disease.

This study suggests that delusions are a risk factor for physical aggression in patients with probable Alzheimer's disease who have moderate to severe cognitive impairment.

Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.

Information regarding the characteristic phenomenology of the behavioral symptoms studied was used to design a clinical rating instrument for AD patients, the Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD), which should be useful in prospective studies of behavioral symptoms as well as in pharmacologic trials.

Alzheimer's disease with delusions and hallucinations

It is demonstrated that AD patients with delusions and hallucinations have a greater degree of cerebral dysfunction and a relatively focal neuropsychological defect, which may indicate a localized pathologic abnormality.